LATEST
Cencora agreed to acquire American Oncology NetworknewAPEX / KorainewSmith & Wesson Brands agreed to acquire Long Range IntermediatenewBose acquired SkullcandyMaximus Federal Services agreed to acquire Agile DefenseMount Logan Management agreed to acquire Alternative Fund AdvisorsDime Commercial Bancshares / ES BancsharesSalesforce agreed to acquire BrazeJV Investors / Oro Mobility HoldingsMorgan Stanley Capital Partners acquired The Rapid GroupCBRE Group agreed to acquire Onnec GroupBevPoint Capital agreed to acquire ESG
Open App
ClosedPublished 22 Dec 2022

Johnson & Johnson /
Abiomed

Johnson & Johnson completes purchase of Abiomed

Price
$16.6bn
Stage
Closed
Buy side: Johnson & Johnson
Buy sideJohnson & Johnson
Target: Abiomed
TargetAbiomed
Source · 22 Dec 2022
See the source
Buy side: Johnson & Johnson
Buy sideJohnson & Johnson
Target: Abiomed
TargetAbiomed
01 / BuyerJohnson & Johnson
02 / TargetAbiomed
01

What happened

Johnson & Johnson completed its acquisition of Abiomed for approximately $16.6 billion, according to a filing dated Dec. 22, 2022.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Johnson & Johnson completes purchase of Abiomed

This document is the source for the companies, stage, figure and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Announced

    The source this page is built from.

  2. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.